Beta Drugs Limited — Board Meeting, 20-07-2026: Outcome of Board Meeting
20-07-2026 | 09:00 am
20-07-2026 | 09:00 am
Beta Drugs announced strong Q1FY27 consolidated results. Sales rose 25.3% to Rs 125.55 Cr, while Net Profit surged 40.9% to Rs 16.5 Cr. This performance was driven by robust segment growth and reduced finance costs, with a positive outlook reiterated.
No comments yet. Be the first to comment!
